Background
The subgranular zone (SGZ) of the hippocampus maintains the capacity for neurogenesis throughout life [
1,
2]. Radial glia-like quiescent neural stem cells express nestin or/and sex-determining region Y-box 2 (Sox2) as well as glial fibrillary acidic protein (GFAP), which, in turn, give rise to proliferating amplifying neuronal progenitors [
3,
4]. In a process of differentiation, cells committed to a neuronal lineage lose these markers and acquire markers associated with immature neurons or neuroblasts, such as doublecortin (DCX), neuron-specific class III β-tubulin (recognized by Tuj-1 antibody), and polysialylated-neural cell adhesion molecule (PSA-NCAM). In vitro, most hippocampal progenitors become neurons; therefore, hippocampal neural stem cells are typically referred to as “neuronal progenitor cells” (NPC) [
2,
5]. However, in vivo, ~ 25% of NPC differentiate into glial cells, comprising astrocytes and oligodendrocytes, and express cell-specific markers [
4]. Astrocytes express the glial fibrillary acidic protein (GFAP) and S100 calcium-binding protein B (S100β) [
4]. Oligodendrocyte precursors express platelet-derived growth factor α receptor (PDGFαR), neural glial antigen 2 (Ng2), and oligodendrocyte transcription factor 1 (Olig1) and Olig2, while mature oligodendrocytes lose these markers and begin to express O4 [
6]. Over time, these newly added neurons incorporate into the functional hippocampal circuitry.
In animal models, abnormal hippocampal neurogenesis has been attributed to cognitive impairment, spatial memory, and learning deficits [
7], and its potential role in depression [
8,
9] has been widely discussed. Little is known about the role of neurogenesis in the normal adult human hippocampus, despite studies showing the presence of hippocampal neurogenesis in both human and primate adult brain [
10‐
13]. Low proliferation capacity of human hippocampal NPC isolated from surgically removed specimens correlates with memory dysfunction in these patients [
14], and antidepressant treatment significantly increases NPC in both murine and human hippocampus [
8,
15,
16], suggesting that changes in NPC can have functional consequences in adult humans as well.
It has been shown that inflammation contributes to the decline in adult hippocampal neurogenesis [
17‐
19]. Microglial cells, which are resident macrophages in the central nervous system (CNS), respond to signals from the peripheral immune system or to local insults, inducing neuroinflammation and releasing proinflammatory cytokines [
20]. Thus, mice treated with bacterial endotoxin lipopolysaccharide (LPS) mimicking acute and intensive systemic inflammation demonstrate upregulation of multiple proinflammatory cytokines that can negatively affect hippocampal neurogenesis [
18,
21‐
23].
Chemokines are induced in astrocytes and activated microglia in response to injury [
24,
25], attract immune cells to sites of tissue damage, and enhance the inflammatory response by inducing the release of inflammatory cytokines and chemokines by neutrophils [
26].
Chemokine growth-regulated oncogene α Gro1, also known as C-X-C motif ligand (CXCL) 1 or keratinocyte-derived chemokine (KC), signals through G protein-coupled receptor CXC receptor 2 (CXCR2); the human ortholog of Gro1 is interleukin (IL)-8, or CXCL8. (Both human CXCL8 and murine CXCL1 protein are here referred to as Gro1.) Gro1 is expressed in neurons and endothelial cells during status epilepticus in rats [
27] and in mice after inflammatory stimuli in both endothelial cells and astrocytes [
28‐
32]. In humans, Gro1 is induced in the brains of sepsis patients [
33]. In vitro, cytokines interleukin (IL)-1β and tumor necrosis factor α (TNFα) induce Gro1 in murine astrocytes [
34] and neuronal precursors [
35]
.
Gro1 transcription is regulated by nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) transcription factor, which, in turn, is activated by proinflammatory cytokines such as IL-1β, IL-6, and TNFα. NFκB-dependent Gro1 induction has been observed in multiple cell types, including neurons [
36], pancreatic β cells [
37], and a melanoma cell line [
38].
Chemokines and their receptors are also expressed in the normal brain that is free of inflammation [
39]. CXCR2 is constitutively expressed in NPC [
40], and Gro1 and CXCR2 are involved in spatial and temporal regulation of oligodendrocyte proliferation in the spinal cord [
41,
42] and promote oligodendrocyte maturation of neuronal stem cells [
35]. Of note, Gro1 acts synergistically with PDGF expressed in astrocytes and neurons [
41], stimulating proliferation of PDGFαR-positive oligodendrocyte progenitors and arresting their migration [
43,
44].
Very little is known about the role of Gro1 in hippocampal neurogenesis. Here, we describe the effects of Gro1 on adult hippocampal human and murine NPC and on the HT-22 murine hippocampal neuronal cell line. We show that Gro1 activated the senescence pathway, as evidenced by induction of senescence-associated β-galactosidase (SA-β gal) and the cell cycle suppressing protein p16, and was associated with decreased expression of Ki67, a marker of proliferation. High Gro1 negatively affected neuronal lineage, decreasing proliferation of neuroblasts positive for Tuj-1 and DCX. Similar results were obtained in vivo, where electroporation of plasmid expressing Gro1 in the hippocampus of newborn mice led to decreased DCX expression, while PDGFαR was elevated.
We also show that Gro1 response to systemic inflammation is sex-dependent. Intraperitoneal injection of lipopolysaccharide (LPS) induced Gro1 expression in the male hippocampus, but the response was blunted in females, and treatment with 17-β estradiol (E2) reduced LPS-triggered Gro1 expression in male mice.
These findings outline new mechanisms underlying aberrant hippocampal neurogenesis and suggest a previously unknown sex-specific influence of Gro1 on neurogenesis during inflammation. These findings may be linked to age- and sex-specific differences in the incidence and symptoms of neuropsychiatric and neurodegenerative disorders.
Methods
Human samples
Human NPC were obtained using surgical hippocampal specimens of patients with mesial temporal lobe epilepsy undergoing partial removal of the hippocampus for an attempted surgical cure (Table
1).
Table 1
Patient characteristics
#1 | Male | 45 | Right hippocampus | Depth electrodes | 12 | 13 | Hippocampal gliosis |
#2 | Male | 44 | Left hippocampus | Depth electrodes | 10 | 22 | Normal hippocampus |
#3 | Female | 44 | Right hippocampus | Depth electrodes | 10 | 7 | Hippocampal sclerosis and gliosis |
Experimental animals and treatments
In vivo electroporation
mGro1 plasmid was mixed with episomal pCagg-hyPbase and a transposable ubiquitin C promoter-driven EGFP reporter plasmid at a 1:0.7:1 ratio. This mix was delivered by injection through pulled glass capillary pipette to P0-P2 C57Bl/6 mice. Pups were then electroporated with electrodes positioned to target the right dorsal hippocampus. Employing Signagel, platinum Tweezertrodes were used for electroporation with 3–5 pulses of 115–135 V (50 ms; separated by 950 ms) generated with the ECM 830 BTX Electroporator (Harvard Apparatus) [
45]. Control mice were electroporated with plasmid lacking Gro1. Animals were killed on day 10 after the procedure, the brains were immediately dissected in phosphate-buffered saline (PBS), and electroporated left halves of the brain were fixed in 4% PFA for at least 6 h at 4 °C. On the following day, the brains were embedded in 4% LMP agarose and sectioned at 70 or 250 μm thickness on a Leica VT1200S vibratome, and EGFP expression was analyzed with confocal Leica Sp5-X microscope. The whole hippocampi were isolated from the electroporated halves of the brain for further analysis.
LPS administration
Two-month-old C57Bl/6 male and female mice (Jackson Laboratory) were injected with LPS (1 mg/kg, in 200 μL of normal saline [NS], i.p.; Sigma-Aldridge) once a day for 5 days. Control mice received NS. Mice were killed 3 h after the last injection.
E2 pellets and LPS administration
Two-month-old C57Bl/6 male mice were surgically implanted under isoflurane anesthesia with E2 (2.5 mg/pellet, 41.666 μg/day release; Innovative Research of America, Sarasota, FL) or placebo pellets for 7 weeks. Five days before the mice were sacrificed, LPS or NS was injected as described above. Mice were killed 3 h after the last injection. There were thus four experimental groups: Placebo/NS, Placebo/LPS, E2/ NS, and E2/LPS.
Adult NPC cultures and treatments
Human NPC was isolated from three individual surgical specimens (Table
1). All patients had electrodes (1.5 mm diameter) implanted in the region of the seizure focus prior to surgical resection, which were removed on average 10 weeks before surgery. The hippocampus was resected, and a piece of hippocampal tissue approximately 2 cm × 1 cm was placed into 30 mL of DMEM media (Corning-Cellgro cat#10-017-CV) with antibiotic-antimycotic (Gemini Bio-Products cat#400-101). Tissue was processed within an hour after dissection. Tissue was dissociated using Papain Dissociation System (Worthington Biochemicals). Cells were isolated according to published protocols [
14,
46‐
48]. Human NPC were then cultured using NeuroCult NS-A Basal Medium (human, cat# 05750; StemCell Technologies) supplemented with NeuroCult NS-A Proliferation Supplement (human, cat #05753; StemCell Technologies) as well as 2 mM
l-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 10 ng/mL h bFGF, and 20 ng/mL hEGF.
Murine NPC cultures were prepared according to published protocols [
2,
15,
49,
50]. Murine NPC were isolated from ten pooled hippocampi of 2-month-old C57Bl/6 mice. NPC were cultured in NeuroCult NSC Basal Medium (mouse, cat#05700) with Proliferation Supplement (mouse, cat # 057012 mM),
l-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 10 ng/mL m bFGF, and 20 ng/mL mEGF in Costar 6-Well Plate with Ultra-Low Attachment Surface (Corning, cat# 3471).
For both human and murine cultures, after 2 weeks in proliferation conditions, neurospheres were collected, cells dispersed by pipetting, and plated in plates pretreated with ECL cell Attachment Matrix (Upstate, 5–10 μg/cm
2) at a density of 2.5–5 × 10
5 per well in 6-well plates or 2–5 × 10
4 per well in 24-well plates (Basal NeuroCult NSC media with Differentiation Supplement, StemCell Technologies, human cat# 05754, and mouse cat# 05703). Cells were placed in differentiating media and allowed to attach for 4–6 h and then treated. Both human and murine NPC were differentiated in the presence of 10 ng/mL IL-1β (Millipore, hIL-1β cat# IL038, mIL-1β cat# IL014) or 50 ng/mL IL-6 (Millipore, hIL-6 cat#IL006, mIL-6 cat# IL017) for 10 days. In some experiments, murine NPC was treated with mGro1 protein (Origen, cat# TP 723259) for 72 h. We used the dose of 80 ng/mL appeared to be the most effective in HT-22 cells (Fig.
7).
Constructs and transfections
Lentiviral particles expressing human Gro1 (EF1-luc2-Gro1-Ubic) and control lentiviral particles were generated at the Cedars-Sinai Virus Core facility. Lentiviral particles expressing shmGro1 or shScr RNAi were purchased (Santa Cruz Biotechnologies).
For lentiviral transduction, cells growing in proliferating conditions were collected, plated into 6-well plates at a density of 5 × 105 per well, placed in differentiating media, and allowed to attach to plastic for 4–6 h before 20 multiplicity of infection (MOI) of virus was added with 3 μg/mL polybrene (Santa Cruz Biotechnologies, cat# sc-134220). After 24 h, cells were washed and fresh media was added. Cells were collected 72 h after transduction.
Cells
HT-22 (Millipore, cat# SCC129) is an immortalized mouse hippocampal cell line subcloned from the HT-4 cell line [
51]. The parental HT-4 cell line was derived from the immortalization of mouse neuronal tissues with a temperature sensitive SV40 T-antigen [
52]. HT-22 cells were cultured and propagated in DMEM with 10% FBS, 2 mM
l-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, and 20 ng/mL mEGF. Cells were treated with murine Gro1 and harvested after 72 h.
Quantitative real-time polymerase chain reaction
Total RNA was isolated from the hippocampi with RNeasy Lipid Tissue Mini Kit (Qiagen, cat# 74804). cDNA was synthesized from 0.5 to 1 μg of purified RNA by iScript Reverse Transcription Supermix (Bio-Rad, cat# 1708841) according to the manufacturer’s instructions. Quantitative PCR was performed in 20 μL reaction using IQ SYBR Green Master Mix and CFX96 Real-Time System standard protocol (Bio-Rad Laboratories, Hercules, CA). Specific validated primers for murine DCX, Ng2, Gro1, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), as well as human Gro1, fibroblast growth factor 2 (FGF2), and glial cell-derived neurotrophic factor (GDNF), were purchased (SuperArray, Qiagen, Germantown, MD). Triplicate PCR reactions yielded threshold cycle (Ct) average, with a coefficient of variance of < 0.05%, which were used to determine ΔCt values [ΔCt = Ct of the target gene minus Ct of the housekeeping GAPDH gene]. A comparative threshold cycle (CT) method was used for relative gene expression quantification. All experiments included template-free (water) and reverse transcriptase-minus controls to ensure no contamination. Relative quantities of mRNA in experimental samples were determined, normalized to GAPDH, and expressed in arbitrary units as fold difference from control (control was taken as 1).
Protein isolation and Western blot analysis
NPC growing in culture were collected in Trizol reagent (Thermo Fisher Scientific, Waltham, MA) and proteins isolated according to the protocol (Molecular Research Center) using radioimmunoprecipitation assay (RIPA) buffer (Cell Signaling, cat#9806) with Protease Inhibitor Cocktail (Sigma, cat# P8340). Western blot analysis was performed as described [
22]. Thirty to fifty micrograms of protein lysate was resolved by SDS-PAGE and electroblotted onto polyvinylidene difluoride (PVDF) membrane (EMD Millipore, Billerica, MA). The membrane was blocked by 5% non-fat dry milk in Tris-buffered saline (TBST; 50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.05% Tween 20) and incubated overnight with primary antibodies at 4 °C, followed by incubation with corresponding secondary antibodies (Sigma-Aldrich, St. Louis, MO) for 2 h at room temperature. Immunoreactive bands were detected using Bio-Rad Molecular Imager® ChemiDoc™ XRS and Image Lab™ Software (BioRad Laboratories). The following antibodies were used: Gro1 (Novus cat# NBP1-51188), SA-β-gal (LSBio cat# LS-B10989), DCX (Santa Cruz Biotechnologies, cat# sc-271390), Tuj-1 (Abcam,cat# ab182-07), Ng2 (Millipore, cat# AB5320), total p65 (Santa Cruz Biotechnologies, cat# sc-8008), phospho-p65 (Ser536; Cell Signaling, cat# 3033), murine Gro1 (R&D, cat# AF-453), GFAP (Millipore, cat# mAB3402), cleaved caspase 3 (Cell Signaling, cat# 9664), Ki67 (Abcam, cat# ab15580), p16 (Santa Cruz Biotechnologies, cat# sc-1661), ionized calcium-binding adapter molecule 1 (Iba1; Abcam, cat# ab107159), PDGFαR (LSBio, cat# LS-B6056), and GAPDH (Cell Signaling, cat #5174).
Immunohistochemistry and immunocytochemistry
To detect Gro1 in SGZ of the hippocampus, the right half of the brain from three randomly selected mice was fixed and sections from 0.36 to 0.6 mm lateral to the midline [
53] were cut. Five randomly selected slides from each mouse were analyzed. Paraffin-embedded brain sagittal sections (5 μm) were double-labeled with primary antibodies conjugated with Alexa 488 or Alexa 568 fluorescent dyes (1:400, Thermo Fisher). The following primary antibodies were used: mouse Gro1 (RnD, cat# AF-453), Sox2 (Millipore, cat#AB56030), DCX (Abcam, cat# ab18723), and GFAP (Millipore, cat# MAB3402 or Abcam, cat# ab7260). Nuclear DNA was stained with DAPI (Sigma, cat#D9542), and the stained sections were covered with ProLong Gold (Thermo Fisher, cat#P36935). Antigen retrieval was performed on paraffin-embedded tissues in Target Retrieval Solution (Dako, cat# S1699).
Neurospheres growing in proliferation media for 2 weeks were collected, dissociated by pipetting with a micropipette, and plated on coverslips pretreated with ECL matrix in 24-well plates in differentiation media. Cells were allowed to attach to coverslips for 4–6 h and then treated. Areas with the highest cell density were imaged with Leica × 20 Plan-Apo lens on a Leica Sp5-X confocal microscope. The number of double positive and total cells was counted in 5–15 fields in two independent experiments (total number of cells analyzed was between 500 and 3000 depending on the experiment). The following primary antibodies were used: Tuj-1 (Stem Cell Technology, cat# 01409 or Abcam, cat# ab182-07), Ng2 (Millipore, cat# AB5320), GFAP (Millipore, cat# MAB3402 or Abcam, cat# ab7260), Ki67 (Abcam, cat#ab15580), DCX (Abcam cat#ab18723), and p16 (Santa Cruz cat# sc-1207 or sc-1661).
SA-β-galactosidase activity
SA-β-galactosidase enzymatic activity was assayed in vitro using a β-gal staining kit (Senescence Cell Staining Kit, Sigma-Aldrich) according to the manual. Briefly, 10,000 cells were plated in 12-well plates, treated for the indicated times, washed with PBS (pH 6.0), fixed, and stained with 5-bromo-4-chloro-3-indolyl-h-d-galactopyranoside (X-Gal) overnight at 37 °C. Only senescent cells stain at pH 6.0. SA-β-gal positivity was assessed in 6-well plates in triplicate, with 1000 cells per field counted in three fields per well.
Statistical analysis
Differences in protein and mRNA levels were assessed by one or two-way ANOVA followed by Tukey’s test to correct for post-hoc multiple testing. The number of cells positive for Ki67, Ng2, Tuj-1, p16, or GFAP across the groups was assessed with a two-tailed t test. For all testing, data were log transformed prior to analysis where data were not normally distributed. Results were inspected to confirm fit. Differences were considered statistically significant at the two-tailed p value of < 0.05.
Discussion
We show here that the chemokine Gro1 induced in response to inflammation triggers senescence and arrests development of new neurons in the hippocampus and that the magnitude of this response is sex-dependent.
In mouse brain, Gro1 is expressed in Sox2-positive neuronal progenitors, but not in DCX-positive neurons or astrocytes. In both human and murine NPC, and in the murine hippocampus, inflammatory stimuli induce Gro1 transcription and translation.
Our results indicate that Gro1 triggers premature senescence in newly developing neurons. Cellular senescence is a state in which the cell stays metabolically active but loses the ability to proliferate in response to growth factor. Cell cycle arrest usually occurs upon activation of cell cycle kinase inhibitors such as p21 or p16 [
59]. Treatment with Gro1 resulted in marked induction of the senescence marker SA-β gal in hippocampal NPC, along with decreased Ki67 and induced p16 indicating decreased cell proliferation. DCX and Tuj-1 were both suppressed, showing a decrease in neuron development, while Ng2, a marker of oligodendrocytes, was elevated. These findings were buttressed by our immunocytochemistry results showing that the number of proliferating Ki67+/Tuj-1+ neuroblasts was decreased following Gro1 treatment while the number of proliferating Ki67+/Ng2+ oligodendrocyte progenitors was increased.
Treatment of HT-22 hippocampal neurons with Gro1 led to very similar results. With this cell line, we also found reduced DCX and Tuj-1 expression, as well as induction of SA-β gal, and a marked increase in the number of senescence neurons. Our results are supported by others showing that chemokine signaling via the Gro1 receptor CXCR2 in human fibroblasts reinforces senescence [
60]. We further confirmed that Gro1 may limit the proliferation of progenitors of neuronal lineage via senescence by demonstrating reduced SA-β gal as well as markedly upregulated DCX expression in Gro1-suppressed murine NPC indicative of increased numbers of neuroblasts. Concordant with our previous observations, PDGFαR was downregulated in cells where Gro1 was low. Senescence is accompanied by a decrease in apoptosis [
56,
59,
61], and we found that Gro1 suppressed cleaved caspase 3 expression in both murine NPC and HT-22 cells. At the same time, oligodendrocyte progenitor markers were increased, in agreement with the findings that Gro1 increases proliferation and survival of oligodendrocytes [
42‐
44,
62]. Together, these results indicate that Gro1 induced in response to inflammation shifts hippocampal neurogenesis toward oligodendrocytes, suppressing new neuron development.
Senescent cells secrete the full array of chemokines, cytokines, and growth factors, a phenomenon termed senescence-associated secretome (SAS) [
63‐
65]. In multiple cell types, Gro1 appears to be a part of SAS [
54,
63,
66]. Some of these secretome factors may actually enhance the senescence phenotype [
59,
65], as evidenced by Gro1 induction of senescence in cancer-associated fibroblasts via an autocrine loop [
67]. Our data suggest that Gro1 induced in response to inflammation may trigger senescence in neuronal stem cells or neuroblasts, but not in astrocytes or oligodendrocytes. Further studies are required to unravel these cell-specific Gro1 effects.
Further, our in vivo results show that Gro1 overexpression in the hippocampus of newborn mice also results in decreased DCX expression. In the newborn brain, expression of SA-β gal in Gro1-treated mice was undetectable, while p16 was upregulated. As the marker of oligodendrocyte progenitors PDGFαR was increased, it is likely that this cell cycle arrest was specific to neuroblast proliferation.
LPS treatment evokes strong systemic inflammation in a sequence of events, including blood-brain barrier leakage [
68], massive peripheral immune cells infiltration [
69], and neuroinflammation. Proinflammatory cytokines are released in the periphery, and cytokines such as IL-1β, TNF-α, and IL-6 are induced in the hippocampus in microglia and astrocytes [
18]. Cytokines have been linked to detrimental effects on neurogenesis [
17‐
19,
23], and we and others [
31] show that proinflammatory cytokines stimulate Gro1 expression. We demonstrate here that IL-1β is markedly induced in the hippocampus in response to inflammation. Sustained IL-1β expression also results in infiltration of neutrophils and macrophages, and the presence of immune cells is coincident with upregulation of Gro1 in the hippocampus [
70]. Therefore, in the course of inflammation, Gro1 may be released from all these multiple sources [
71,
72].
Following LPS treatment, we found significantly induced Gr0o1(Gro1) in the male hippocampus and a blunted response in females. This may be attributed to the blunted IL-1β response to LPS, which we observed both in female mice and in male mice treated with E2.
The hippocampus contains estrogen receptors ERα and ERβ [
73,
74], and hippocampal NPC also express both receptors [
75]. Estrogen has been shown to exert a dual effect on Gro1. E2 suppresses Gro1 expression in rodent models at inflammatory sites limiting LPS-induced recruitment of neutrophils, thus limiting Gro1 delivery to the hippocampus [
76]. In addition, during acute inflammation, estrogens have been shown to decrease Gro1 expression by enhancing the production and limiting the degradation of the NFκB inhibitor nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha (IκBα). This arrests NFκB nuclear translocation and suppresses Gro1 transcription [
76,
77].
Our results suggest that during inflammation, E2, by dampening Gro1 response, may, to some extent, protect female neurogenesis from detrimental acute intense inflammatory stimuli. Sexual dimorphism in Gro1 response to inflammation may therefore be contingent on the level of E2 in females.
A number of limitations should be considered. First, the mechanisms underlying cell-specific effects of Gro1 in NPC, with induced p16 in neuroblasts but suppressed expression in glial progenitors, remain unknown. Second, we tested the effects of LPS on hippocampal Gro1 expression in males and females but did not evaluate how the stage of the estrus cycle in females might further influence outcomes. Third, E2 pellets were implanted in males with intact levels of testosterone, a hormone that can also have protective effects on neurogenesis. Nevertheless, despite these limitations, this study broadens our knowledge and opens new approaches for understanding mechanisms underlying new neuron development in the adult brain.